Cour Pharmaceutical Development Co. Inc. published data in Science Translational Medicine showing the potential of Immune Modifying Nanoparticles (IMP) to reduce inflammation and promote tissue repair and regeneration in patients who have suffered a heart attack.

The U.S. Food and Drug Administration (FDA) cleared Radius Medical LLC’s Prodigy Support Catheter. Engineered to provide back-up support to guidewires, the Prodigy Support Catheter is intended for use in treating chronic total occlusions.

Patients in the European Union (EU) received the first Veniti Vici Venous Stent System implants to treat symptomatic venous outflow obstruction of the lower extremities.

Men with enlarged prostates can find relief with a non-surgical treatment that shrinks the gland, suggests research done on more than 100 patients and presented at the 26th annual International Symposium on Endovascular Therapy (ISET).

Six-month results of the ESPRIT trial suggest a bioresorbable drug-eluting scaffold is effective in opening blocked blood vessels in the legs and pelvis, as presented at the 26th annual International Symposium on Endovascular Therapy (ISET). 

Peripheral artery disease (PAD) sufferers maintain improved quality of life, including being able to walk farther, three years after being treated with stents to open their blocked leg arteries, according to STROLL trial results presented at the 26th annual International Symposium on Endovascular Therapy (ISET).

FDA Premarket Approval PMA Clinical Study EP Lab Cath Leads Implantable Devices

The U.S. Food and Drug Administration (FDA) has approved many cardiac implantable electronic device models currently in use through a review process in which models were deemed safe and effective based on approval of prior versions of the device, according to a study published in JAMA.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now